MetaCap

Radiopharm Theranostics Statistics

NASDAQ: RADXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.6304-0.0678 (-9.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Radiopharm Theranostics by the numbers

Radiopharm Theranostics has a market capitalization of $9.9 million based on 15.70M shares outstanding. With trailing EPS of $-3.64, Radiopharm Theranostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.4% below its 50-day average and 81.2% below its 200-day average.

Average daily trading volume is 55.23K shares, or about $34,814 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RADX valuation vs. peer median

RADX compared with the median of 8 peer companies
MetricRADXPeer medianDifference
Market cap$9.90M$9.26M+7%
Avg. volume55.23K91.27K-39%

Peer median across 8 companies: ASBP, CMMB, BFRI, AEON, GDTC, CALC, OPTH, BIVI.

Valuation

Price / sales (latest FY)
2.72
EPS (TTM)
$-3.64

Price and trading

Previous close
0.6982
Open
0.7159
Day range
0.63 – 0.716
52-week range
0.63 – 16.25
52-week change
-86.15%
Beta
—
Volume
12.98K

Dividends and events

Additional statistics

Market Cap
9.90M
Forward Pe
-0.27
Eps
-3.64
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
16.25
Week52 Low
0.63
Avg Volume
55,225.00
Shares Outstanding
15.70M
Ma50
1.15
Ma200
3.36
Pct From52w High
-96.12%
Pct From52w Low
0.06%

Related